CRISPR-based lateral flow (SHERLOCK/DETECTR)
Cas12/Cas13 collateral-cleavage diagnostics that read a pathogen's genome on a paper strip — CRISPR as the recognition layer, lateral flow as the readout, isothermal amplification as the engine. The table carries three vendors with fully sourced dossier ledgers; the field's wider players are named in the note, not padded into the table.
1 · What it gives
CRISPR diagnostics repurpose the defense machinery of bacteria into a test: a guide RNA directs a Cas12 or Cas13 enzyme to a target sequence, and on finding it the enzyme shreds any single-stranded reporter in the vicinity — a collateral-cleavage burst that converts molecular recognition into a visible signal on a paper strip. The architecture solves the two problems that kept molecular diagnostics out of point-of-care: it needs no thermocycler (isothermal amplification feeds the CRISPR step) and no instrument (lateral flow reads the result by eye). SHERLOCK (Cas13) and DETECTR (Cas12) — the platform names the field inherited from its founding papers — reached regulated products fast: Sherlock Biosciences took the first CRISPR-based FDA Emergency Use Authorization for SARS-CoV-2 in May 2020 and now runs an ISO 13485-certified manufacturing facility in Swavesey, UK sized for 5 million diagnostic devices annually; Mammoth Biosciences, with $375 million raised, holds a FDA EUA for its DETECTR BOOST SARS-CoV-2 Reagent Kit and runs high-throughput capacity of 1,500 tests per 8-hour shift in CLIA laboratories; and BGI industrialized the readout-adjacent layer at population scale — 3.705 billion CNY revenue for fiscal 2025, NMPA emergency approvals for its COVID-19 detection kits, EU CE certification for nucleic-acid and antigen kits, and an Addis Ababa factory producing 10 million test kits a year.
Key directions of CRISPR-based lateral flow diagnostics:
- Collateral-cleavage signal chemistry (Cas12/Cas13 Reporters): guide-programmed recognition amplified into a shredded-reporter signal — the core reaction SHERLOCK and DETECTR turned into platform families.
- Emergency-use to IVD conversion (Regulated Products): first CRISPR-based FDA EUA (Sherlock Biosciences, SARS-CoV-2, May 2020), DETECTR BOOST EUA (Mammoth, 2022), and the post-emergency path to ordinary IVD review under FDA and IVDR regimes.
- Instrument-free point-of-care format (Paper-Strip Readout): lateral flow strips that read by eye, fed by isothermal amplification — capacity of 1,500 tests per 8-hour shift in CLIA laboratories shows the operational form.
- Population-scale manufacturing (Million-Kit Plants): ISO 13485-certified lines sized at 5 million devices annually (Sherlock’s Swavesey facility) and a 10-million-kits-per-year factory in Addis Ababa (BGI) — manufacturing as the deployment bottleneck.
Sectoral value chain#
[guide RNA design] ──> [reaction formulation] ──> [amplification + CRISPR detection]
│
(reporter cleavage signal)
│
▼
[clinical decision] <── [distribution, cold chain] <── [strip manufacturing, QC]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Guide design | target-sequence-specific gRNA panels | In: pathogen genomes. Out: guide RNA sets. |
| Reaction formulation | enzyme, gRNA, reporter, amplification mix | In: enzymes, oligos, reagents. Out: lyophilizable test chemistry. |
| Strip manufacturing | lateral flow strips under ISO 13485 | In: test chemistry, strip materials. Out: up to 5 million devices/yr lines. |
| Amplification | isothermal pre-amplification of target | In: sample extract. Out: amplified target for CRISPR step. |
| Detection and readout | collateral cleavage, visual strip read | In: amplified target. Out: eye-readable result. |
| Regulated deployment | EUA/IVDR/NMPA-reviewed use | In: released kits. Out: clinical decisions at point of care. |
Cross-cutting technologies of the sector:
- Isothermal amplification (LAMP/RPA): the thermocycler-free engine that feeds the CRISPR detection step.
- Lyophilized reagent formats (Ambient-Stable Kits): the packaging that makes strip diagnostics survivable outside cold chains.
- Nucleic-acid extraction at point of care (Sample Prep): the unglamorous front end that decides field performance.
2 · What it replaces 2 · matched by industry
| D2E4 | Crop disease forecasting models, spore traps, pheromone and smart pest traps and field diagnostics — spray when risk is real instead of calendar-based fungicide and insecticide programmes Replaces: Fixed-interval ("calendar") protective fungicide sprays and routine insecticide applications regardless of pest pressure | EAC |
| D2E– | On-farm culture, PCR panels, rapid tests and veterinary laboratory services for livestock and aquaculture — treat what is diagnosed instead of blanket and prophylactic antibiotic treatment Replaces: Blanket treatment of every clinical mastitis case, group metaphylaxis on suspicion, prophylactic antibiotics in hatcheries and ponds, … | DIAG |
3 · How to implement 6 steps
- 1Guide and assay designTesting & analyticsPathogen genomes are screened for target sequences the guide RNA can claim uniquely — design is where false positives are prevented before any chemistry exists.Who can do this step matched automatically✓ GMP industrial scale“ProBio: A global CRDMO (contract research, development, and manufacturing organization) providing end-to-end solutions for biologics and cell and gene therapy (CGT).”Vaxxinova Norway Norwayindustrial scale“Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.”Turion Labs Singapore“Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”Rovita GmbH Germany“As an accredited laboratory, our partner Focus Foodlabs offers extensive services in the field of food analysis and food safety.”
- 2Reagent manufactureContract manufacturing (CMO/CDMO)Cas enzymes, guide RNAs, reporters and amplification reagents are produced under device-grade quality — the input chemistry every strip inherits.Who can do this step matched automaticallyCell AgriTech Malaysia5,000 L industrial scale“At Cell AgriTech, we position ourselves as Asia’s first dedicated CDMO for cultivated meat and plant cell culture.”450,000 tons/year“They control the entire life cycle from feed to processing and emphasize sustainable practices and B2B OEM/private-label growth alongside the Sa Giang consumer brand.”Luzhou Pack China120,000 tons industrial scale“It is worth mentioning that we have established long-term partnership with more than 103 global brands and hundreds of medium-large scale importers coming from the United States, …”✓ GMP industrial scale“ProBio: subsidiary providing end-to-end CDMO services from drug discovery to commercialization, with focus on CGT, antibodies, and recombinant protein drugs to accelerate …”
- 3Strip manufacture and lyophilizationContract manufacturing (CMO/CDMO)Purification & downstreamStrips are manufactured and the reaction is dried onto them under ISO 13485 — capacity lines at 5 million devices per year (Swavesey) are sized for national campaigns, not laboratory menus.Who can do this step matched automatically✓ GMP 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”Cell AgriTech Malaysia5,000 L industrial scale“At Cell AgriTech, we position ourselves as Asia’s first dedicated CDMO for cultivated meat and plant cell culture.”450,000 tons/year“They control the entire life cycle from feed to processing and emphasize sustainable practices and B2B OEM/private-label growth alongside the Sa Giang consumer brand.”Luzhou Pack China120,000 tons industrial scale“It is worth mentioning that we have established long-term partnership with more than 103 global brands and hundreds of medium-large scale importers coming from the United States, …”
- 4QC and lot releaseTesting & analyticsLots are released against performance standards — the step that converts a laboratory reaction into a regulated diagnostic a regulator can trace.Who can do this step matched automatically✓ GMP industrial scale“ProBio: A global CRDMO (contract research, development, and manufacturing organization) providing end-to-end solutions for biologics and cell and gene therapy (CGT).”Vaxxinova Norway Norwayindustrial scale“Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.”Turion Labs Singapore“Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”Rovita GmbH Germany“As an accredited laboratory, our partner Focus Foodlabs offers extensive services in the field of food analysis and food safety.”
- 5DistributionDistribution & market accessKits ship at ambient or cold-chain temperature depending on format; BGI’s Addis Ababa factory shows the localization form distribution takes at population scale.Who can do this step matched automaticallyBioceres Crop Solutions (NASDAQ: BIOX) Argentina“Longstanding relationships with dealers and distributors”Luzhou Pack China120,000 tons industrial scale“It is worth mentioning that we have established long-term partnership with more than 103 global brands and hundreds of medium-large scale importers coming from the United States, …”CRUST Group Singapore50,000L“Technology centers on fermentation and extraction to “valorise” ingredients, delivered via a plug-and-play valorisation-as-a-service model (Stand-Alone wholesale, White Label …”30,000tons industrial scale“2025-08-01 [5 Compartment Disposable Lunch Tray Sugarcane Bagasse Fiber Sustainable Portable Oil Proof Wholesale To Go – Shaoneng Group Guangdong Luzhou Eco Technology Co., Ltd.”
- 6Point-of-care runExtraction, isothermal amplification and strip read happen where the patient is — 1,500 tests per 8-hour shift per CLIA site is the operational throughput the format reaches.
4 · Who delivers
Matched suppliers (matched automatically)
| Pairwise | United States | Research / RTO | active |
| Switch Flow Resources Sdn Bhd | Malaysia | Services / consulting | active |
| Becton Dickinson | United States | Producer | active |
| Shandong Shunfeng Biotechnology | China | Producer | active |
| OnDemandBio | South Korea | Research / RTO | active |
| Andermatt Group | Switzerland | Producer | active |
| General Poultry Company B.S.C. | Bahrain | Producer | active |
| Kubota Environmental Service | Japan | Producer | active |
| Alfa Laval | Sweden | Producer | active |
| Petruz Group | Brazil | Producer | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Sherlock Biosciences | 🇺🇸 USA | SHERLOCK CRISPR diagnostics | First CRISPR FDA EUA (SARS-CoV-2, 2020); ISO 13485 Swavesey facility; 5 m devices/yr capacity; grant-funded revenue | Commercial |
| Mammoth Biosciences | 🇺🇸 USA | DETECTR platform | DETECTR BOOST EUA (2022); $375 m raised; 1,500 tests/8-h shift; CLIA laboratory operation | Commercial |
| BGI | 🇨🇳 China | Nucleic-acid testing manufacturing | CNY 3.705 bn FY2025 revenue; NMPA emergency approvals; CE-certified kits; 10 m kits/yr Ethiopia factory | Commercial |
5 · Rules & route to market
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The US invented the platform families and hosts both CRISPR-diagnostics pure-plays; the FDA’s emergency-use pathway is what carried their first products to market.
Platform founding labs, EUA products, venture scale#
- Sherlock Biosciences (Cambridge, MA): the SHERLOCK platform company — first CRISPR-based FDA Emergency Use Authorization for SARS-CoV-2 (May 2020), an ISO 13485-certified manufacturing facility in Swavesey, UK sized for 5 million diagnostic devices annually, with revenue primarily grant-funded as of December 2024.
- Mammoth Biosciences (Brisbane, CA): the DETECTR platform company — $375 million raised to date, FDA EUA for DETECTR BOOST SARS-CoV-2 Reagent Kit received in 2022, high-throughput capacity of 1,500 tests per 8-hour shift, tests performed in high-complexity CLIA laboratories, with a planned Abu Dhabi advanced-therapy manufacturing facility.
- FDA emergency pathway as launch rail: both companies’ first regulated products shipped under EUA — the same pathway that later IVD conversions must graduate from.
European Union
Europe contributes the IVDR certification regime that all post-emergency CRISPR diagnostics must clear for European deployment, and hosts one leg of Sherlock’s manufacturing.
IVDR certification, UK manufacturing site, post-emergency conversion#
- Sherlock’s Swavesey facility (UK): an ISO 13485-certified manufacturing site at Buckingway Business Park — approximately 45 employees as of 2023 — the European manufacturing leg of the platform’s first mover.
- IVDR as the European gate: emergency-era products must convert to certified IVDs under IVDR 2017/746 for European deployment — the same evidentiary conversion the cfDNA field already ran.
- CE marking as export currency: BGI’s CE-certified monkeypox and COVID-19 kits show the marking’s reach beyond Europe — CE-marked kits flow through markets the IVDR does not govern.
China
China industrialized the readout-adjacent layer at population scale; BGI’s testing infrastructure shows what manufacturing depth CRISPR diagnostics will inherit as the platform converts to ordinary IVD products.
BGI’s testing manufacturing, NMPA emergency approvals, kit export#
- BGI (Shenzhen): 3.705 billion CNY revenue for fiscal 2025, NMPA emergency approval for COVID-19 detection kits and the DNBSEQ-T7 sequencing system, EU CE certification for monkeypox nucleic-acid and COVID-19 antigen kits.
- Manufacturing at population scale: a COVID-19 testing kit factory in Addis Ababa, Ethiopia with annual output of 10 million kits — the export form of Chinese diagnostics manufacturing that CRISPR formats will ride.
- NMPA emergency track: China’s emergency-approval route moved detection kits to market at pandemic speed — the regulatory channel CRISPR-based products would use for the next pathogen.
6 · Money: tenders & grants
No open tender or grant matched right now.
7 · Tech stack & innovations
The stack is three layers — recognition, amplification, readout — and its innovations are about collapsing them into a strip a nurse can run.
- Collateral-cleavage detection chemistry (Cas Reporters):
- Cas12/Cas13 enzymes activated by target binding shred fluorescent or lateral-flow reporters — molecular specificity becomes a visible line.
- case: SHERLOCK (Cas13) and DETECTR (Cas12) platform families, both carrying FDA EUAs for SARS-CoV-2.
- Isothermal amplification feeding CRISPR (Thermocycler-Free):
- LAMP/RPA pre-amplification runs at constant temperature, removing the instrument that separated molecular tests from point of care.
- case: Mammoth’s 1,500-tests-per-8-hour-shift high-throughput system in CLIA laboratories.
- Manufacturing-grade strip production (ISO 13485 Lines):
- diagnostics become logistics: lyophilized chemistry on strips manufactured and released like any regulated device.
- case: Sherlock’s Swavesey facility sized for 5 million devices annually; BGI’s Addis Ababa factory at 10 million kits per year.
Sources 3 · 0 independent · 3 producer sites
Producers' own sites 3
- axelkra.us · orasure.com · sherlock.bio · www.cambridgeindependent.co.uk producer checked 2026-09-18
- drupal.prod.genomeweb.com · m42.ae · mammoth.bio · www.businesswire.com producer checked 2026-09-18
- en.genomics.cn · en.genomics.cn · en.genomics.cn · static.cninfo.com.cn producer checked 2026-09-18